These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34958629)

  • 1. A novel approach to augment single-arm clinical studies with real-world data.
    Sachdeva A; Tiwari RC; Guha S
    J Biopharm Stat; 2022 Jan; 32(1):141-157. PubMed ID: 34958629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propensity-score-based meta-analytic predictive prior for incorporating real-world and historical data.
    Liu M; Bunn V; Hupf B; Lin J; Lin J
    Stat Med; 2021 Sep; 40(22):4794-4808. PubMed ID: 34126656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leverage multiple real-world data sources in single-arm medical device clinical studies.
    Lu N; Wang C; Chen WC; Li H; Song C; Tiwari R; Xu Y; Yue LQ
    J Biopharm Stat; 2022 Jan; 32(1):107-123. PubMed ID: 33844621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propensity score-integrated composite likelihood approach for incorporating real-world evidence in single-arm clinical studies.
    Wang C; Lu N; Chen WC; Li H; Tiwari R; Xu Y; Yue LQ
    J Biopharm Stat; 2020 May; 30(3):495-507. PubMed ID: 31707908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trial designs using real-world data: The changing landscape of the regulatory approval process.
    Baumfeld Andre E; Reynolds R; Caubel P; Azoulay L; Dreyer NA
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1201-1212. PubMed ID: 31823482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matching within a hybrid RCT/RWD: framework on associated causal estimands.
    Lin J; Yu G; Gamalo M
    J Biopharm Stat; 2023 Jul; 33(4):439-451. PubMed ID: 35929973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditional borrowing external data to establish a hybrid control arm in randomized clinical trials.
    Li H; Tiwari R; Li QH
    J Biopharm Stat; 2022 Nov; 32(6):954-968. PubMed ID: 35067183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propensity score-integrated power prior approach for augmenting the control arm of a randomized controlled trial by incorporating multiple external data sources.
    Lu N; Wang C; Chen WC; Li H; Song C; Tiwari R; Xu Y; Yue LQ
    J Biopharm Stat; 2022 Jan; 32(1):158-169. PubMed ID: 34756158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propensity score-integrated power prior approach for incorporating real-world evidence in single-arm clinical studies.
    Wang C; Li H; Chen WC; Lu N; Tiwari R; Xu Y; Yue LQ
    J Biopharm Stat; 2019; 29(5):731-748. PubMed ID: 31530111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Improved Matching Practice for Augmenting a Randomized Clinical Trial with External Control.
    Li J; Du Y; Liu H; Yi Y
    Ther Innov Regul Sci; 2023 May; 57(3):611-618. PubMed ID: 36809484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matching design for augmenting the control arm of a randomized controlled trial using real-world data.
    Liu Y; Lu B; Foster R; Zhang Y; Zhong ZJ; Chen MH; Sun P
    J Biopharm Stat; 2022 Jan; 32(1):124-140. PubMed ID: 35098880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propensity score-integrated composite likelihood approach for augmenting the control arm of a randomized controlled trial by incorporating real-world data.
    Chen WC; Wang C; Li H; Lu N; Tiwari R; Xu Y; Yue LQ
    J Biopharm Stat; 2020 May; 30(3):508-520. PubMed ID: 32370640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propensity score-integrated approach to survival analysis: leveraging external evidence in single-arm studies.
    Chen WC; Lu N; Wang C; Li H; Song C; Tiwari R; Xu Y; Yue LQ
    J Biopharm Stat; 2022 May; 32(3):400-413. PubMed ID: 35675348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid clinical trials to generate real-world evidence: design considerations from a sponsor's perspective.
    Zhu M; Sridhar S; Hollingsworth R; Chit A; Kimball T; Murmello K; Greenberg M; Gurunathan S; Chen J
    Contemp Clin Trials; 2020 Jul; 94():105856. PubMed ID: 31669449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propensity score-based methods for causal inference and external data leveraging in regulatory settings: From basic ideas to implementation.
    Li H; Yue LQ
    Pharm Stat; 2023; 22(4):721-738. PubMed ID: 36794571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of real-world evidence in regulatory decisions for rare diseases in the United States-Current status and future directions.
    Wu J; Wang C; Toh S; Pisa FE; Bauer L
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1213-1218. PubMed ID: 32003065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contributions of Real-World Evidence and Real-World Data to Decision-Making in the Management of Soft Tissue Sarcomas.
    Demetri GD; Stacchiotti S
    Oncology; 2021; 99 Suppl 1():3-7. PubMed ID: 33853076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propensity score-integrated Bayesian prior approaches for augmented control designs: a simulation study.
    Wang X; Suttner L; Jemielita T; Li X
    J Biopharm Stat; 2022 Jan; 32(1):170-190. PubMed ID: 34939894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world evidence to support regulatory decision-making for medicines: Considerations for external control arms.
    Burcu M; Dreyer NA; Franklin JM; Blum MD; Critchlow CW; Perfetto EM; Zhou W
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1228-1235. PubMed ID: 32162381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semi-supervised mixture multi-source exchangeability model for leveraging real-world data in clinical trials.
    Haine LMF; Murry TA; Nahra R; Touloumi G; Fernández-Cruz E; Petoumenos K; Koopmeiners JS
    Biostatistics; 2023 Sep; ():. PubMed ID: 37697901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.